
The Netherlands
UMC Utrecht
UMC Utrecht uses Sterilwave as part of a broader approach to processing infectious clinical waste and demonstrates its operational and quantitative value.
View sourceReferences & evidence
Customer references, laboratory evidence, conformity records and regulatory sources are presented with a clear source and scope.
Operational and programme evidence
A hospital reference, an independent programme evaluation and a European assessment make performance and implementation conditions tangible.

The Netherlands
UMC Utrecht uses Sterilwave as part of a broader approach to processing infectious clinical waste and demonstrates its operational and quantitative value.
View sourceSenegal
An independent UNIDO evaluation documents operation of Sterilwave 100 in Tivaouane and also identifies training and continuity as critical success factors.
View sourceEuropean Union
CINEA documents support for environmental-benefit assessment, DNSH and possible reuse routes for treated Sterilwave residue.
View sourceSimpleComply in the Benelux
SimpleComply translates Sterilwave evidence into the actual waste stream, site conditions, permits, validation, business case and daily operation of each organisation.
View SimpleComply services →Independent validation
A certificate, laboratory test and operational reference do not prove the same thing.
NF X 30-503 tests report 7.41 to 8.68 log10 reduction. Four regrowth tests recorded 0 CFU/g through day 28.
Report EZEM-2021-08-00009 documents off-gas measurements before and after HEPA and carbon filtration.
Report 16/0691 records more than 4 log10 inactivation in all tested samples, consistent with STAATT Level III.
Model-specific conformity records and ISO certifications support quality management but are not stand-alone microbiological evidence.
Each additional log step is a further tenfold reduction. Log values are test results, not a blanket guarantee for every waste stream or site.
Regulatory & European evidence
France
Circular DGS/EA1/DGPR/2012-335 addresses Sterilwave for pre-treatment by decontamination of infectious healthcare waste, with technical requirements and excluded streams.
View official sourceEurope
CINEA describes support for assessing environmental benefits, DNSH and potential reuse routes for treated residue under European environmental conditions.
View European sourceApplication note: Applicability and waste acceptance remain dependent on country, waste stream, model and site conditions.
Next step
SimpleComply translates the available evidence into your acceptance matrix, validation plan, permit strategy, business case and implementation requirements.
Discuss your evidence needs